Cargando…

Inhibition of sodium glucose cotransporter 2 (SGLT2) delays liver fibrosis in a medaka model of nonalcoholic steatohepatitis (NASH)

The rise in the incidence of nonalcoholic steatohepatitis (NASH) has necessitated the development of an effective prevention methodology. An antidiabetic drug, belonging to the group of sodium glucose cotransporter 2 (SGLT2) inhibitors, has been tested for its therapeutic effect on NASH; however, no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goto, Ryo, Kamimura, Kenya, Shinagawa‐Kobayashi, Yoko, Sakai, Norihiro, Nagoya, Takuro, Niwa, Yusuke, Ko, Masayoshi, Ogawa, Kohei, Inoue, Ryosuke, Yokoo, Takeshi, Sakamaki, Akira, Kamimura, Hiroteru, Abe, Satoshi, Nishina, Hiroshi, Terai, Shuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443870/ https://www.ncbi.nlm.nih.gov/pubmed/30984539 http://dx.doi.org/10.1002/2211-5463.12598

Ejemplares similares

Inhibition of sodium‐glucose cotransporter 2 ameliorates renal injury in a novel medaka model of nonalcoholic steatohepatitis‐related kidney disease
por: Nagoya, Takuro, et al.
Publicado: (2019)

Effective prevention of sorafenib-related vascular damage induced adverse events and maintenance of hepatic function by dried bonito broth and histidine
por: Sakai, Norihiro, et al.
Publicado: (2019)

Effect of Diphtheria Toxin-Based Gene Therapy for Hepatocellular Carcinoma
por: Kamimura, Kenya, et al.
Publicado: (2020)

Effect of a neural relay on liver regeneration in mice: activation of serotonin release from the gastrointestinal tract
por: Inoue, Ryosuke, et al.
Publicado: (2018)

Involvement of the liver-gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A
por: Owaki, Takashi, et al.
Publicado: (2022)

Considerations of elderly factors to manage the complication of liver cirrhosis in elderly patients
por: Kamimura, Kenya, et al.
Publicado: (2019)

Autonomic nervous system network and liver regeneration
por: Kamimura, Kenya, et al.
Publicado: (2018)

Correction: Medaka as a model for human nonalcoholic steatohepatitis
por: Matsumoto, Toshihiko, et al.
Publicado: (2023)

Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2021)

Correction: Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2023)

Telmisartan improves nonalcoholic steatohepatitis in medaka (Oryzias latipes) by reducing macrophage infiltration and fat accumulation
por: Kuwashiro, Shinya, et al.
Publicado: (2011)

Diagnosis and management of fibromuscular dysplasia and segmental arterial mediolysis in gastroenterology field: A mini-review
por: Ko, Masayoshi, et al.
Publicado: (2018)

Renal Impairment in Chronic Hepatitis B: A Review
por: Kamimura, Hiroteru, et al.
Publicado: (2018)

Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses
por: Kamimura, Kenya, et al.
Publicado: (2017)

HBx and YAP expression could promote tumor development and progression in HBV-related hepatocellular carcinoma
por: Oda, Chiyumi, et al.
Publicado: (2022)

Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis
por: Sakamaki, Akira, et al.
Publicado: (2020)

Rare complication of hepatocellular carcinoma in Wilson's disease
por: Ohkoshi‐Yamada, Marina, et al.
Publicado: (2021)

The prognosis and incidence of hepatic encephalopathy of patients with liver cirrhosis treated with proton pump inhibitors: A multicenter retrospective study in Japan
por: Sakamaki, Akira, et al.
Publicado: (2021)

Rare Mesenteric Arterial Diseases: Fibromuscular Dysplasia and Segmental Arterial Mediolysis and Literature Review
por: Ko, Masayoshi, et al.
Publicado: (2019)

The burden of nonalcoholic steatohepatitis (NASH) in the United States
por: Tapper, Elliot B., et al.
Publicado: (2023)

Involvement of DNA Damage Response via the Ccndbp1–Atm–Chk2 Pathway in Mice with Dextran-Sodium-Sulfate-Induced Colitis
por: Horigome, Ryoko, et al.
Publicado: (2022)

Effective prevention of sorafenib-induced hand–foot syndrome by dried-bonito broth
por: Kamimura, Kenya, et al.
Publicado: (2018)

Gene Therapy for Pancreatic Diseases: Current Status
por: Kamimura, Kenya, et al.
Publicado: (2018)

Cyclin D1 Binding Protein 1 Responds to DNA Damage through the ATM–CHK2 Pathway
por: Niwa, Yusuke, et al.
Publicado: (2022)

Nonalcoholic steatohepatitis (NASH) is associated with cardiac remodeling and dysfunction
por: Simon, Tracey G., et al.
Publicado: (2017)

Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH)
por: Qi, Xiaoyan, et al.
Publicado: (2022)

Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies
por: Kobayashi, Takamasa, et al.
Publicado: (2018)

Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy
por: Kobayashi, Takamasa, et al.
Publicado: (2018)

Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial
por: Kamimura, Kenya, et al.
Publicado: (2017)

Efficacy and Safety of Pancreas-Targeted Hydrodynamic Gene Delivery in Rats
por: Ogawa, Kohei, et al.
Publicado: (2017)

Machine learning prediction model for treatment responders in patients with primary biliary cholangitis
por: Kimura, Naruhiro, et al.
Publicado: (2023)

A Novel Animal Model of Nonalcoholic Steatohepatitis (NASH): Hypoxemia Enhances the Development of NASH
por: Takayama, Fusako, et al.
Publicado: (2009)

Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
por: Sakai, Norihiro, et al.
Publicado: (2023)

Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma
por: Kutlu, Ozlem, et al.
Publicado: (2018)

A new method to induce nonalcoholic steatohepatitis (NASH) in mice
por: Savari, Feryal, et al.
Publicado: (2019)

Image-Guided Hydrodynamic Gene Delivery: Current Status and Future Directions
por: Kamimura, Kenya, et al.
Publicado: (2015)

Use of a Deep Learning Approach for the Sensitive Prediction of Hepatitis B Surface Antigen Levels in Inactive Carrier Patients
por: Kamimura, Hiroteru, et al.
Publicado: (2022)

Gene Therapy for Liver Cancers: Current Status from Basic to Clinics
por: Kamimura, Kenya, et al.
Publicado: (2019)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
por: Drescher, Hannah K., et al.
Publicado: (2019)

Effect of Lenvatinib on a Hepatocellular Carcinoma with Fibroblast Growth Factor Receptor 4 Expression: A Case Report and Review of the Literature
por: Shibata, Osamu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bsjf39p3bfl29belg5sfdhnle1